Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose
- PMID: 1910085
- PMCID: PMC1180115
- DOI: 10.1113/jphysiol.1991.sp018673
Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose
Abstract
1. Healthy humans ingested the dipeptide carnosine (L-beta-alanyl-L-histidine). Their plasma levels and urinary outputs of carnosine and beta-alanine were monitored over the following 5 h. 2. Large amounts of intact carnosine (up to 14% of the ingested dose) were recovered in the urine over the 5 h after ingestion. However, carnosine was undetectable in the plasma unless precautions were taken to inhibit blood carnosinase activity ex vivo during and after blood collection. 3. The amount of carnosine recovered in urine varied substantially between subjects. It correlated negatively with carnosinase enzymic activity in the plasma. Highest carnosinase activities were observed in those subjects who regularly underwent physical training. 4. Urinary recovery of the disaccharide lactulose also varied considerably between subjects, but was substantially lower than that of carnosine. There was no significant correlation between the recoveries of carnosine and lactulose. 5. When lactulose was ingested with a hypertonic solution, the urinary recovery of lactulose was generally increased. When carnosine was ingested with a hypertonic solution, the urinary recovery of carnosine was reduced: hence the paracellular route probably is not dominant for absorption of intact carnosine. 6. Intact carnosine must have crossed the intestine to an extent much greater than hitherto recognized. Rapid post-absorptive hydrolysis is a severe obstacle to quantification of intact peptide absorption.
Similar articles
-
Effects of pre- and post-absorptive factors on the lactulose/rhamnose gut permeability test.Clin Sci (Lond). 2000 Mar;98(3):349-53. doi: 10.1042/cs19990274. Clin Sci (Lond). 2000. PMID: 10677394 Clinical Trial.
-
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.BMC Gastroenterol. 2007 Jun 19;7:23. doi: 10.1186/1471-230X-7-23. BMC Gastroenterol. 2007. PMID: 17578566 Free PMC article. Clinical Trial.
-
Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.Eur J Gastroenterol Hepatol. 2007 Mar;19(3):245-50. doi: 10.1097/MEG.0b013e328011093c. Eur J Gastroenterol Hepatol. 2007. PMID: 17301652 Clinical Trial.
-
Impairment of jejunal absorption rate of carnosine by glycylglycine in man in vivo.Gut. 1976 Apr;17(4):252-7. doi: 10.1136/gut.17.4.252. Gut. 1976. PMID: 773786 Free PMC article. Review.
-
Effect of beta-alanine supplementation on muscle carnosine concentrations and exercise performance.Amino Acids. 2010 Jul;39(2):321-33. doi: 10.1007/s00726-009-0443-4. Epub 2009 Dec 20. Amino Acids. 2010. PMID: 20091069 Review.
Cited by
-
Carnosine treatment for gulf war illness: a randomized controlled trial.Glob J Health Sci. 2013 Feb 4;5(3):69-81. doi: 10.5539/gjhs.v5n3p69. Glob J Health Sci. 2013. PMID: 23618477 Free PMC article. Clinical Trial.
-
The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer.Cells. 2023 Nov 8;12(22):2592. doi: 10.3390/cells12222592. Cells. 2023. PMID: 37998326 Free PMC article. Review.
-
The ergogenic effect of acute carnosine and anserine supplementation: dosing, timing, and underlying mechanism.J Int Soc Sports Nutr. 2022 Mar 26;19(1):70-91. doi: 10.1080/15502783.2022.2053300. eCollection 2022. J Int Soc Sports Nutr. 2022. PMID: 35599917 Free PMC article.
-
Dietary Carnosine Supplementation in Healthy Human Volunteers: A Safety, Tolerability, Plasma and Brain Concentration Study.Nutrients. 2025 Jun 27;17(13):2130. doi: 10.3390/nu17132130. Nutrients. 2025. PMID: 40647235 Free PMC article.
-
Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.Pharm Res. 1996 Aug;13(8):1213-8. doi: 10.1023/a:1016068421243. Pharm Res. 1996. PMID: 8865315
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources